Back to Search
JOSEPH LEVIN, MD
MD
Emergency Medicine Physician
NPI: 1720466733IndividualAccepts Medicare
Specialties, Licenses & Credentials
Emergency Medicine PhysicianPrimary
Emergency Medicine
Code: 207P00000X
290984(NY)
CMS Specialties
PrimaryEMERGENCY MEDICINE
Education
OTHER
Class of 2015
Research & Publications (20)
The design and synthesis of aryl hydroxamic acid inhibitors of MMPs and TACE.
PMID 15320727·Curr Top Med Chem·2004
6-review
Increased alpha-synuclein aggregation following limited cleavage by certain matrix metalloproteinases.
PMID 19022250·Exp Neurol·2009
8-other
Objective measurement of muscle rigidity in Parkinsonian patients treated with subthalamic stimulation.
PMID 18855925·Mov Disord·2009
8-other
Essential tremor leading to toxic liver damage successfully treated with deep brain stimulation.
PMID 19290467·Acta Neurochir (Wien)·2009
5-case
Acetylenic TACE inhibitors. Part 3: Thiomorpholine sulfonamide hydroxamates.
PMID 16426848·Bioorg Med Chem Lett·2006
7-preclinical
Single particle analysis of manganese-induced prion protein aggregates.
PMID 15766554·Biochem Biophys Res Commun·2005
8-other
Acetylenic TACE inhibitors. Part 2: SAR of six-membered cyclic sulfonamide hydroxamates.
PMID 16084720·Bioorg Med Chem Lett·2005
7-preclinical
Benzodiazepine inhibitors of the MMPs and TACE. Part 2.
PMID 15261259·Bioorg Med Chem Lett·2004
7-preclinical
Acetylenic TACE inhibitors. Part 1. SAR of the acyclic sulfonamide hydroxamates.
PMID 12873518·Bioorg Med Chem Lett·2003
8-other
Sulfonate ester hydroxamic acids as potent and selective inhibitors of TACE enzyme.
PMID 15553924·Drug Des Discov·2003
8-other
Anthranilate sulfonamide hydroxamate TACE inhibitors. Part 2: SAR of the acetylenic P1' group.
PMID 11934588·Bioorg Med Chem Lett·2002
8-other
Heteroaryl and cycloalkyl sulfonamide hydroxamic acid inhibitors of matrix metalloproteinases.
PMID 11206468·Bioorg Med Chem Lett·2001
7-preclinical
The discovery of anthranilic acid-based MMP inhibitors. Part 2: SAR of the 5-position and P1(1) groups.
PMID 11514167·Bioorg Med Chem Lett·2001
8-other
The discovery of anthranilic acid-based MMP inhibitors. Part 1: SAR of the 3-position.
PMID 11206467·Bioorg Med Chem Lett·2001
7-preclinical
The discovery of anthranilic acid-based MMP inhibitors. Part 3: incorporation of basic amines.
PMID 11677139·Bioorg Med Chem Lett·2001
7-preclinical
Families and Schools Together: an experimental study of multi-family support groups for children at risk.
PMID 19480887·J Sch Psychol·2009
4-observational
3,4-Disubstituted benzofuran P1' MMP-13 inhibitors: optimization of selectivity and reduction of protein binding.
PMID 19625186·Bioorg Med Chem Lett·2009
7-preclinical
Mortality and loss-to-follow-up during the pre-treatment period in an antiretroviral therapy programme under normal health service conditions in Uganda.
PMID 19671185·BMC Public Health·2009
8-other
Synthesis and activity of quinolinylmethyl P1' alpha-sulfone piperidine hydroxamate inhibitors of TACE.
PMID 19464885·Bioorg Med Chem Lett·2009
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 550 1ST AVE
NEW YORK, NY 10016 - Phone
- (212) 263-5506
Quick Facts
- NPI
- 1720466733
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 11
- Publications
- 20
Are you this provider?
Claim Your Profile